You are here: Industry Insights > cancer

News List

Sugary Sodas, Juices Tied to Higher Cancer Risk drugs
July 11, 2019
Sugary Sodas, Juices Tied to Higher Cancer Risk.
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric drugs
July 11, 2019
Focus on Ovarian Cancer Surgical Volume May Not Be Best Metric.
Extended Follow-Up Supports Low-Dose CT for Lung Cancer Screening drugs
July 09, 2019
Extended Follow-Up Supports Low-Dose CT for Lung Cancer Screening.
NICE endorses dacomitinib for treatment of lung cancer europeanpharmaceuticalreview
July 09, 2019
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
New study showing drug prolongs life for patients with ovarian cancer worldpharmanews
July 05, 2019
New study showing drug prolongs life for patients with ovarian cancer.
Sports playbook helps doctors predict cancer patient outcomes worldpharmanews
July 05, 2019
Sports playbook helps doctors predict cancer patient outcomes.
Urine Biomarker Helps Classify Risk Level in Prostate Cancer drugs
July 04, 2019
Urine Biomarker Helps Classify Risk Level in Prostate Cancer.
Image-Based Model Predicts Radiation Tx Failure in Lung Cancer drugs
July 04, 2019
Image-Based Model Predicts Radiation Tx Failure in Lung Cancer.
Millions of Life Years, Billions of Dollars Lost to Cancer Each Year drugs
July 04, 2019
More than 8.7 million years of life and about $94 billion in earnings were lost to cancer in the United States in 2015, researchers say.
Zirabev gets FDA approval to treat five types of cancer pharmaceutical-technology
July 03, 2019
Pfizer has secured US Food and Drug Administration (FDA) approval for Zirabev (bevacizumab-bvzr), a biosimilar to Roche’s Avastin (bevacizumab).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page